Key Takeaways
- Volume-led growth, margin sacrificed for market share: Consolidated volumes rose ~15% QoQ, but management deliberately cut prices to fill newly expanded capacity, compressing margins. The bet is that share gains today convert to higher margins once utilization rises.
- PLI income timing distorts the margin story: Q2 margins were flattered by INR12 cr of prior-year PLI recognition; Q3 had none, so the sequential drop looks steeper than the underlying operational trend. Another INR9-10 cr is due but will only be booked on approval, likely in H1 FY26.
- API is a drag today, a regulatory unlock tomorrow: The domestic API business is running below breakeven on overheads. Four CEPs have been filed, with approvals and first regulated-market sales possible from Q2 FY26, which management argues will lift both volumes and margins materially.
- Balance sheet stretched by growth: Finance costs doubled QoQ as working capital swelled on higher receivables and wood pulp inventory build. Management has now capped inventory and set a target to bring receivables down to 90 days.
- What to watch next quarter: Whether the CCS environmental clearance actually arrives in 4 weeks, the pace of MCC utilization ramp toward the 50% Q4 target, and any sign that the receivables reduction target is being met.
Volume, Pricing & the Margin Trade-off
- Consolidated volume up, stand-alone down: Consolidated volume reached ~5,400 MT, a ~15% QoQ increase, but stand-alone volume declined 4.2% (from 4,618 MT to 4,424 MT) because Q2 is historically a stronger quarter than Q3. The subsidiaries sell independently and can procure from anywhere, so consolidated and stand-alone volumes diverge.
- Deliberate price cuts to fill capacity: Management acknowledged reducing prices to penetrate the market after bringing expanded capacity online. The strategy is to secure market share first, then raise prices and margins gradually once the position is established.
- Margin walk: Q3 margins were lower than Q2 primarily because Q2 included ~INR12 cr of PLI income from prior years. The underlying operational margin also reflects the pricing strategy and higher depreciation after CWIP was capitalized on 30 September 2024.
- Overhead absorption is the margin recovery engine: As MCC utilization rises from ~50% targeted in Q4 FY25 toward 80-90% by Q4 FY26, overheads per unit will fall and margins will increase. The payback period on investments is around 3 years, with full returns expected by FY27.
Reddy: "Because we expanded capacities comes into operational, then we are -- to penetrate into the market, some price reductions we've done. And then once that is settled down, slowly, gradually, we'll increase, and then our margins will also go up. First we are concentrating on market share."
API Segment: The Regulatory Bet
- Currently a margin drag: The domestic API business is not covering its overheads; margins are very low. The company is not tracking capacity utilization here, instead focusing on balancing costs through domestic sales while building the regulatory filing pipeline.
- The CEP pathway: Four CEPs have been filed out of nine targeted for this fiscal year. Approvals are expected possibly from Q2 FY26, with first sales into regulated markets from Q2 or Q3 FY26. Regulated-market API margins are expected to be materially higher than domestic.
- Growth ambition: API is expected to grow 25-30%, and management claims its contribution in FY27 will be "far, far more" than the 15% an analyst suggested, though no specific figure was committed.
Sinha: "So possibly from Q2, we should be looking at having our -- in the Q2, we should be looking at having our CEP approvals. And possibly from Q2, if not from Q3, we should be having sales into the regulated markets as well."
Capacity Expansion & Project Updates
- MCC ramp plan: New capacity is expected to reach 50% utilization in Q4 FY25 and 80-90% by Q4 FY26. Full utilization thereafter will bring overheads down and margins up.
- CCS project: Environmental clearance is expected in the next 4 weeks, with civil works to commence immediately after. Currently only boundary wall and non-CEC activities are underway. Management expressed definite confidence in receiving the approval this quarter.
- CWIP now operational: All capital work-in-progress was capitalized on 30 September 2024; no further major capitalization is expected. The resulting depreciation increase is already flowing through the P&L.
- Sultanpur GAIN certification: The facility was audited and approved by Intertek on behalf of GAIN, enabling supply of premium vitamin and mineral premix blends worldwide. This is expected to lift the food and nutra revenue share, though no specific target was given.
Sinha: "Yes. Yes, Manav. This time we are definitely confident."
Balance Sheet & Working Capital
- Finance costs doubled QoQ: The increase was driven by company growth, higher working capital, increased DSOs, and higher inventory built in anticipation of wood pulp price increases. Management has now decided not to increase stock further.
- Receivables target: A target has been set for the sales team to reduce receivables to 90 days, though no deadline was specified.
- Warrant conversion: INR16 cr has already been received from warrant holders, with the deadline around 5-6 February. If an investor fails to pay, the 25% already paid will be forfeited and recognized as direct income to the company.
- Tax tailwind: The ~25-26% tax rate benefits from the Dahej SEZ and will continue for the next 2-3 years.
Subsidiaries & Other Segments
- Sigachi Arabia: Currently loss-making, with the loss described as very small and only operational in nature (no setup costs). Volume needs to increase to absorb overheads; the unit is expected to turn positive in another 2 quarters.
- Trimax API unit: The balance 20% stake is to be acquired within 3 years, at the purchaser's call option.
- O&M share: Other income as a percentage of revenue fell from 9% to 8% because other income rose, though absolute O&M figures increased.
- PLI recognition policy: The company follows a conservative, approval-based recognition policy. The INR17 cr shown in Q2 pertained to FY23 and FY24. This year's PLI of INR9-10 cr is expected to be cleared by Q1 or Q2 of next year.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| MCC capacity utilization | Reach 50% utilization | Q4 FY25 |
| MCC capacity utilization | Reach 80-90% utilization | Q4 FY26 |
| Sigachi Arabia profitability | Turn positive | Within 2 quarters |
| CEP approvals | Receive first approvals, begin regulated-market sales | Q2 FY26, or Q3 if delayed |
| CCS environmental clearance | Receive approval | Within 4 weeks / this quarter |
| Receivables reduction | Bring down to 90 days | No deadline set; target assigned to sales team |
| Revenue growth | 25-30% YoY, sustainable; may surpass 30% | Ongoing |
| Investment payback | Full returns from PBT perspective | By FY27 |
| Tax benefit (Dahej SEZ) | ~25-26% effective rate | Next 2-3 years |
| Trimax balance stake acquisition | Acquire remaining 20% | Within 3 years, at purchaser's option |
Key Metrics
| Metric | Q3 FY25 |
|---|---|
| Operating income | ₹139.41 cr, +25.7% YoY |
| EBITDA | ₹33.2 cr, +46.9% YoY |
| EBITDA margin | 23.81% |
| Net profit | ₹20.51 cr, +26.54% YoY |
| PAT margin | 14.7% |
| R&D expenditure | ₹8.85 cr |
| Revenue growth (core excipients, 9M) | +29% YoY |
| Volume growth (core excipients, 9M) | +22.5% YoY |
| MCC volume (consolidated) | 5,400 metric tons |
| MCC volume (standalone) | 4,424 metric tons, -4.2% QoQ from 4,618 metric tons in Q2 |
| New MCC capacity utilization | 35–40%, expected to reach 50% in Q4 FY25 and 80–90% by Q4 FY26 |
| Revenue mix: MCC | 80% of total revenue |
| Revenue mix: O&M | 8% of total revenue, down from 9% last year |
| Revenue mix: API | 7% of total revenue |
| Net debt (long-term) | ₹0, adjusted for fixed deposits; working capital debt ~₹90 cr |
| CEP filings | 4 filed out of 9 targeted for FY25 |
| Credit rating | CARE A- (long-term), CARE A2 (long-term/short-term), stable outlook |
| Tax rate | 25–26%, benefiting from Dahej SEZ; expected for next 2–3 years |
| Depreciation | ₹4.7 cr, up from ₹3.2 cr in Q2 due to CWIP capitalization on 30 Sep 2024 |
| DSO (debtor days) | ~107 days, target to reduce to 90 days |
| PLI income recognized in Q3 | ₹0; Q2 recognized ₹17 cr pertaining to FY23 and FY24; ~₹9–10 cr expected for full year |
| Sigachi Arabia profitability | Loss-making, expected to turn positive in ~2 quarters |